Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Japanese (NIKKEI) Biotech Industry Analysis

UpdatedAug 13, 2025
DataAggregated Company Financials
Companies34
  • 7D-1.0%
  • 3M9.7%
  • 1Y13.8%
  • YTD7.9%

Over the last 7 days, the Biotech industry has remained flat, although notably SanBio gained 6.1%. As for the the longer term, the industry is up 17% over the past 12 months. As for the next few years, earnings are expected to grow by 30% per annum.

Industry Valuation and Performance

Has the Japanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 13 Aug 2025JP¥1.2tJP¥191.4b-JP¥67,580,048,000.00125.1x-17.4x6.1x
Fri, 11 Jul 2025JP¥1.1tJP¥218.2b-JP¥43,671,220,000.0098.8x-25.2x5.1x
Sun, 08 Jun 2025JP¥1.2tJP¥214.8b-JP¥40,595,705,000.0014.7x-29.7x5.6x
Tue, 06 May 2025JP¥1.1tJP¥207.8b-JP¥39,129,850,000.0015x-27.5x5.2x
Thu, 03 Apr 2025JP¥996.7bJP¥207.8b-JP¥39,285,612,000.0015.5x-25.4x4.8x
Sat, 01 Mar 2025JP¥1.0tJP¥207.4b-JP¥38,725,942,000.0015x-26.3x4.9x
Mon, 27 Jan 2025JP¥994.6bJP¥207.3b-JP¥13,514,452,000.0020.8x-73.6x4.8x
Wed, 25 Dec 2024JP¥1.0tJP¥206.4b-JP¥12,718,809,000.0022.6x-82.3x5.1x
Fri, 22 Nov 2024JP¥1.0tJP¥207.5b-JP¥10,798,759,000.0019.9x-95.9x5x
Sun, 20 Oct 2024JP¥1.1tJP¥214.3b-JP¥3,941,502,000.0021.8x-285.1x5.2x
Tue, 17 Sep 2024JP¥1.0tJP¥210.1b-JP¥360,229,000.0018.5x-2889.3x5x
Thu, 15 Aug 2024JP¥978.4bJP¥214.0bJP¥2.3b13x431x4.6x
Sat, 13 Jul 2024JP¥1.1tJP¥187.7b-JP¥15,773,047,000.0095.4x-68.6x5.8x
Mon, 10 Jun 2024JP¥828.7bJP¥195.7b-JP¥14,113,284,000.0096.5x-58.7x4.2x
Wed, 08 May 2024JP¥794.4bJP¥199.1b-JP¥14,617,545,000.0077.6x-54.3x4x
Fri, 05 Apr 2024JP¥752.3bJP¥194.2b-JP¥15,456,803,000.0062.4x-48.7x3.9x
Sun, 03 Mar 2024JP¥814.8bJP¥196.2b-JP¥19,179,997,000.0065.5x-42.5x4.2x
Tue, 30 Jan 2024JP¥774.6bJP¥222.3b-JP¥12,604,827,000.0017.9x-61.5x3.5x
Thu, 28 Dec 2023JP¥792.4bJP¥224.2b-JP¥12,970,409,000.0017.1x-61.1x3.5x
Sat, 25 Nov 2023JP¥805.7bJP¥221.9b-JP¥12,426,487,000.0017.4x-64.8x3.6x
Mon, 23 Oct 2023JP¥741.7bJP¥223.0b-JP¥14,478,735,000.0020.5x-51.2x3.3x
Wed, 20 Sep 2023JP¥865.0bJP¥223.0b-JP¥14,518,735,000.0027x-59.6x3.9x
Fri, 18 Aug 2023JP¥851.3bJP¥225.1b-JP¥19,813,776,000.0048x-43x3.8x
Sun, 16 Jul 2023JP¥927.2bJP¥223.0b-JP¥19,224,669,000.0053.5x-48.2x4.2x
Tue, 13 Jun 2023JP¥984.7bJP¥220.6b-JP¥21,578,670,000.0046.6x-45.6x4.5x
Thu, 11 May 2023JP¥916.4bJP¥218.2b-JP¥20,155,938,000.0021.2x-45.5x4.2x
Sat, 08 Apr 2023JP¥910.0bJP¥218.3b-JP¥21,583,164,000.0021.6x-42.2x4.2x
Mon, 06 Mar 2023JP¥923.3bJP¥216.2b-JP¥18,991,580,000.0020.7x-48.6x4.3x
Wed, 01 Feb 2023JP¥944.8bJP¥186.7b-JP¥24,854,541,000.0039x-38x5.1x
Fri, 30 Dec 2022JP¥902.6bJP¥186.8b-JP¥24,722,604,000.0043.2x-36.5x4.8x
Sun, 27 Nov 2022JP¥906.3bJP¥182.1b-JP¥23,614,604,000.0045.9x-38.4x5x
Tue, 25 Oct 2022JP¥836.1bJP¥176.5b-JP¥24,974,270,000.0046.4x-33.5x4.7x
Thu, 22 Sep 2022JP¥862.2bJP¥176.5b-JP¥24,974,270,000.0044.1x-34.5x4.9x
Sat, 20 Aug 2022JP¥959.9bJP¥174.4b-JP¥21,144,270,000.0021.8x-45.4x5.5x
Price to Earnings Ratio

-45.4x


Total Market Cap: JP¥959.9bTotal Earnings: -JP¥21,144,270,000.00Total Revenue: JP¥174.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Biotech Industry Price to Earnings3Y Average -120.6x202320242025
Current Industry PE
  • Investors are optimistic on the Japanese Biotechs industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 4.6x is lower than the industry's current PS ratio of 6.2x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 3.1% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the Japanese Healthcare industry?

JP Market4.12%
Healthcare-0.55%
Biotech-1.01%
Biotech-1.01%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4592 SanBioJP¥2.76k12.7%
+JP¥22.4b		178.1%PB104.7x
4894 CuoripsJP¥6.40k4.9%
+JP¥2.4b		2.6%PS296.2x
4588 Oncolys BioPharmaJP¥665.0010.5%
+JP¥1.6b		7.3%PS578.8x
4594 BrightPath BiotherapeuticsJP¥79.0012.9%
+JP¥814.4m		36.2%PS6309.6x
4571 NANO MRNALtdJP¥155.007.6%
+JP¥776.5m		-14.8%PS95.1x

Latest News

4588
JP¥628.00
Oncolys BioPharma
7D
6.1%
1Y
3.5%
4974
JP¥866.00
Takara Bio
7D
-5.5%
1Y
-9.3%
4599
JP¥317.00
StemRIM
7D
-3.6%
1Y
-18.3%
2929
JP¥928.00
Pharma Foods International
7D
1.8%
1Y
1.9%
4575
JP¥1,050.00
CanBas
7D
3.1%
1Y
73.8%
4587
JP¥1,589.00
PeptiDream
7D
-5.8%
1Y
-29.4%
4576
JP¥121.00
D. Western Therapeutics Institute
7D
5.2%
1Y
55.1%
7777
JP¥230.00
3-D Matrix
7D
-3.4%
1Y
75.6%

3-D Matrix, Ltd. (TSE:7777) Surges 25% Yet Its Low P/S Is No Reason For Excitement

Aug 01
3-D Matrix, Ltd. (TSE:7777) Surges 25% Yet Its Low P/S Is No Reason For Excitement
7774
JP¥534.00
Japan Tissue Engineering
7D
-8.1%
1Y
1.1%
219A
JP¥3,405.00
Heartseed
7D
-3.4%
1Y
154.9%
2160
JP¥2,900.00
GNI Group
7D
-0.7%
1Y
54.2%
4571
JP¥153.00
NANO MRNALtd
7D
8.5%
1Y
-13.6%
4592
JP¥2,647.00
SanBio
7D
6.1%
1Y
162.3%
4591
JP¥110.00
Ribomic
7D
7.8%
1Y
29.4%
4894
JP¥6,530.00
Cuorips
7D
6.4%
1Y
-5.2%
4593
JP¥630.00
Healios K.K
7D
-2.3%
1Y
279.5%

Is Healios K.K (TSE:4593) Using Too Much Debt?

Jun 20
Is Healios K.K (TSE:4593) Using Too Much Debt?